- $1.17bn
- $1.20bn
- $701.20m
US FDA identifies recall of Avanos Medical's respiratory systems as most serious
Brief: Avanos Medical Appoints Lisa Egbuonu-Davis To Board Of Directors
Avanos Medical Inc reports results for the quarter ended in December - Earnings Summary
Brief: Avanos Medical, Inc. Announces Fourth Quarter And Full-Year 2022 Results
Avanos Medical Inc expected to post earnings of 49cents a share - Earnings Preview
Brief: Avanos Medical Plans To Pursue Efficient Capital Allocation Strategies, Including Through Acquisitions That Meet Strategic And Financial Criteria
Brief: Avanos Medical Inc Appoints Sudhakar Varshney As Senior Vice President, Global Supply Chain & Procurement
Avanos Medical Inc reports results for the quarter ended in September - Earnings Summary
Brief: Avanos Medical, Inc. Announces Third Quarter 2022 Results
Avanos Medical Inc expected to post earnings of 35cents a share - Earnings Preview
Avanos Medical Inc expected to post earnings of 35cents a share - Earnings Preview
NYSE ORDER IMBALANCE 160554.0 SHARES ON BUY SIDE
Avanos Medical Inc reports results for the quarter ended in June - Earnings Summary
Brief: Avanos Medical Inc Announces Second Quarter 2022 Results
Avanos Medical Inc expected to post earnings of 38 cents a share - Earnings Preview
Brief: Avanos Medical Inc Says On June 24, Co Entered Into Credit Agreement With Certain Lenders - SEC Filing
NYSE ORDER IMBALANCE 135164.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 61477.0 SHARES ON SELL SIDE
Brief: Avanos Medical Inc - On May 16, 2022, Approved New One-Year Program Under Which Company May Repurchase Up To $25.0 Million Of Co's Common Stock